EFPIA, the European Federation of Pharmaceutical Industries and Associations, is delighted to invite you to “Clinical Trials at the time of COVID-19 – and beyond”, as part of the series of our virtual events, that will be held on 19 May from 11:00 to 12:00 CEST.
Our company is attending the 5th European Conference on Clinical Research, in Amsterdam next week, on February 10th-11th.
We are looking forward to getting updated on the latest news on pharmaceutical, biotechnology and medical device sectors as well as the regulatory environment with an ultimate aim to improve patients’ health.
Please join us at our stand on the main exhibition hall between coffee breaks, to demo our eClinical Solution, Healthentia. It would be a great pleasure to meet with you and discuss further.
We are looking forward to meeting you in person.
Looking forward to our 2nd marketing Event in Barcelona.
Come and meet us at Booth 3.
The predictive capabilities of traditional, vital-based biomarkers on trial outcomes has been under investigation in clinical trials. However, Real World Data is much more than measured vitals: patient-reported outcomes and physical measurements from trial participants’ lifestyles can provide us with extended biomarkers. Can they be useful in predicting future patient-reported outcomes or even trial outcomes? Can they be used to model patients or to cluster them into behavioural phenotypes? These are questions addressed under the framework of the Sprint #3 workshop, where we will see how AI can support traditional industries, such as Life Sciences, as well as Health, Wellbeing and Ageing. We will also present commercial applications and R&D projects, discussing the challenges and opportunities through the introduction of AI.
We are very excited that Konstantina Kostopoulou will be joining our partners at #DIAEurope2019 in demonstrating our eClinical platform #Healthentia that leverages Real World Evidence and drives clinical insights in clinical trials and patient care.Come and find us at Booth BO3/BO4
Brainstorm the status of the regulatory and ethical scenario in the context of eHealth and expose the state of the art of three EU H2020 eHealth projects discussing the process-to-market implications especially at the light of the Regulatory framework in the clinical research and uptake in the healthcare scenario.
